Ajooni Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Ajooni Biotech has a total shareholder equity of ₹427.1M and total debt of ₹21.7M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are ₹475.2M and ₹48.1M respectively. Ajooni Biotech's EBIT is ₹13.6M making its interest coverage ratio 2.4. It has cash and short-term investments of ₹4.3M.
Key information
5.1%
Debt to equity ratio
₹21.68m
Debt
| Interest coverage ratio | 2.4x |
| Cash | ₹4.28m |
| Equity | ₹427.08m |
| Total liabilities | ₹48.12m |
| Total assets | ₹475.20m |
Recent financial health updates
No updates
Recent updates
Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower
Mar 20
We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease
Nov 10We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease
Jul 13If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late
Feb 16Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 14
Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?
Dec 24Financial Position Analysis
Short Term Liabilities: AJOONI's short term assets (₹323.3M) exceed its short term liabilities (₹30.1M).
Long Term Liabilities: AJOONI's short term assets (₹323.3M) exceed its long term liabilities (₹18.0M).
Debt to Equity History and Analysis
Debt Level: AJOONI's net debt to equity ratio (4.1%) is considered satisfactory.
Reducing Debt: AJOONI's debt to equity ratio has reduced from 39.2% to 5.1% over the past 5 years.
Debt Coverage: AJOONI's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: AJOONI's interest payments on its debt are not well covered by EBIT (2.4x coverage).